StageZero Life Sciences Ltd T.SZLS

DECEMBER MEETING - CONTINGENT SHARE VOTE

[Photoman77]

The December meeting will not involve a RS option so you bashers can stop wetting your beds with excitement.

Care Oncology originally agreed to the deal with StageZero at a much higher price point, yet still proceeded to completed the deal at a huge discount due to sp drop. Many of the people associated with Care Oncology who are financially vested in the StageZero acquisition deal are now with StageZero so their putting a reverse share (rs) option on the table at this time in in their best interest. Plus was already taken off the table this summer.

The meeting in December is for approval of the completed milestone of UK license that requires shareholder approval to release the shares.  --------

8,000,000 common shares contingent upon the achievement of certain milestones ("Milestones") and StageZero shareholder approval (the "Contingent Shares"). In the event the Milestones are achieved, and the StageZero shareholders do not approve of the issuance of the Contingent Shares, StageZero is obligated to pay to Health Clinics Limited, in lieu of the Contingent Shares, CAD $16,000,000, payable at a rate of 9.5% out of StageZero's monthly gross revenues. The Contingent Consideration becomes immediately payable in the event of a take-over bid.

[Mykndrsn]

As i said I believe you're correct but I don't think this single achievement milestone involves all 8,000,000 shares. 

[LithLover]

The UK clinic licence and overall milestones for achieving certain levels of revenue etc are 2 different things: 2,500,000 common shares, contingent upon Clinic Operations Limited obtaining a Care Quality Commission licence in the United Kingdom; 8,000,000 common shares contingent upon the achievement of certain milestones ("Milestones") and StageZero shareholder approval

[Mykndrsn]

So do we vote on releasing the 2,500,000 shares?

[LithLover]

Looks like the 2,500,000 will be given out once a UK licence is approved does not require shareholder approval was part of the deal once license is obtained.  The additional 8,000,000 will be given out once milestones are achieved and provided shareholders approve.  If shareholders don't approve, the 8,000,000 shares will be valued at $16,000,000 ($2/share) and paid out monthly

[Mykndrsn]

Maybe another milestone was acheived that requires issuance approval?